Current trial data suggest that many MCED tests demonstrate high specificity, often above 99% thereby reducing the likelihood of false positives ...
A new test may get to the heart of your dementia risk several years before any symptoms emerge. Dementia, which affects over 6 million Americans, impacts memory, language and problem-solving skills.
A small study found that a blood test could identify whether someone had Chronic Fatigue Syndrome (CFS) with 92% accuracy. Because CFS and long COVID have some biological overlap, this research could ...
Guardant Health is touting the results of a new study showing its Reveal blood test can detect whether chemotherapy is failing months before evidence shows up on regular scans, allowing oncologists to ...
A team of scientists has developed a highly accurate blood test for Chronic Fatigue Syndrome. The test reads tiny DNA patterns that reveal the biological signature of the illness. For millions who’ve ...
A new blood test could speed up diagnosis and treatment for people dealing with early memory or thinking changes. The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to ...
Dr. Omar Al-Heeti is an assistant professor of medicine at Southern Illinois University and practices internal medicine with a specialty in infectious diseases. He received his medical degree from the ...
A blood test for more than 50 types of cancer could significantly boost early detection and speed up diagnosis, according to a new study. Made by U.S. pharmaceutical company Grail, the Galleri test ...
Needle-free devices like TAP and Tasso offer painless blood collection, a benefit for the squeamish. These tests face challenges with sample size and accuracy compared to traditional methods. This ...
FDA cleared the Elecsys pTau181 test as the first blood-based biomarker to aid in the initial assessment of Alzheimer's disease and other causes of cognitive decline that can be used in the primary ...
Researchers believe they have developed the first dedicated blood test to diagnose chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), which has the potential to be a ...
The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...